BBOT

We are developing a therapeutic designed to break the cancer-causing interaction between RAS and PI3Kα that does not harm healthy cells, bypasses glucose metabolism signaling, and avoids hyperglycemia. From company website Source · Oct 13, 2026

Keywords: lung non-small cell carcinoma oncology solid tumors HER2 positive breast cancer